• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Dreyling M, Ghielmini M, Rule S, Salles G, Vitolo U, Ladetto M

出版信息

Ann Oncol. 2017 Dec 1;28(12):3109. doi: 10.1093/annonc/mdx020.

DOI:10.1093/annonc/mdx020
PMID:28327933
Abstract
摘要

相似文献

1
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Dec 1;28(12):3109. doi: 10.1093/annonc/mdx020.
2
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v83-v90. doi: 10.1093/annonc/mdw400.
3
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的滤泡性淋巴瘤：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2011 Sep;22 Suppl 6:vi59-63. doi: 10.1093/annonc/mdr388.
4
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2014 Sep;25 Suppl 3:iii76-82. doi: 10.1093/annonc/mdu200. Epub 2014 Aug 13.
5
Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2009 May;20 Suppl 4:119-20. doi: 10.1093/annonc/mdp148.
6
Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii77-8. doi: 10.1093/annonc/mdn096.
7
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v181-3. doi: 10.1093/annonc/mdq184.
8
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma.欧洲血液学协会（EHA）认可欧洲医学肿瘤学会（ESMO）关于新诊断和复发滤泡性淋巴瘤的临床实践指南。
Hemasphere. 2021 Apr 21;5(5):e559. doi: 10.1097/HS9.0000000000000559. eCollection 2021 May.
9
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的套细胞淋巴瘤：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2014 Sep;25 Suppl 3:iii83-92. doi: 10.1093/annonc/mdu264.
10
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的上皮性卵巢癌：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv259. doi: 10.1093/annonc/mdy157.

引用本文的文献

1
Should Core Needle Lymph Node Biopsy be a Relevant Alternative to Surgical Excisional Biopsy in Diagnostic Work Up of Lymphomas?在淋巴瘤的诊断检查中，粗针淋巴结活检是否应作为手术切除活检的一种相关替代方法？
Eurasian J Med. 2023 Jun;55(2):114-119. doi: 10.5152/eurasianjmed.2023.0060.
2
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy.接受含激素免疫化疗的淋巴瘤患者的糖尿病发病风险及对原有糖尿病的影响。
Blood Adv. 2022 Aug 9;6(15):4427-4435. doi: 10.1182/bloodadvances.2021006859.
3
Follicular Lymphoma in China: Systematic Evaluation of Follicular Lymphoma Prognostic Models.
中国的滤泡性淋巴瘤：滤泡性淋巴瘤预后模型的系统评估
Cancer Manag Res. 2022 Apr 8;14:1385-1393. doi: 10.2147/CMAR.S349193. eCollection 2022.
4
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.在 DAWN 2 期临床试验中，鉴定出一个遗传特征，该特征可使复发/难治性滤泡性淋巴瘤对伊布替尼治疗产生应答。
Cancer Med. 2022 Jan;11(1):61-73. doi: 10.1002/cam4.4422. Epub 2021 Nov 17.
5
Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial).与全科医生合作优化淋巴瘤患者的生存：一项 II 期随机对照试验（GOSPEL I 试验）。
Trials. 2021 Jan 6;22(1):12. doi: 10.1186/s13063-020-04945-4.
6
Orbital and Eyelid B-Cell Lymphoma: A Multicenter Retrospective Study.眼眶及眼睑B细胞淋巴瘤：一项多中心回顾性研究
Cancers (Basel). 2020 Sep 7;12(9):2538. doi: 10.3390/cancers12092538.
7
Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.苯达莫司汀与利妥昔单抗联合替西罗莫司（BeRT）治疗复发套细胞淋巴瘤和滤泡性淋巴瘤的I/II期试验最终结果
Hemasphere. 2020 Jun 8;4(3):e398. doi: 10.1097/HS9.0000000000000398. eCollection 2020 Jun.
8
Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma.早期结内和结外滤泡性淋巴瘤受累野照射联合利妥昔单抗治疗后的肿瘤学结果和复发模式分析。
Strahlenther Onkol. 2020 Aug;196(8):705-714. doi: 10.1007/s00066-020-01624-w. Epub 2020 May 6.
9
Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.在惰性 B 细胞非霍奇金淋巴瘤患者中进行低剂量 2×2Gy 重复放射治疗。
Cancer Med. 2020 Jun;9(11):3725-3732. doi: 10.1002/cam4.2796. Epub 2020 Apr 6.
10
Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study.利妥昔单抗联合受累野照射治疗早期淋巴结滤泡性淋巴瘤：MIR研究结果
Hemasphere. 2018 Nov 30;2(6):e160. doi: 10.1097/HS9.0000000000000160. eCollection 2018 Dec.